Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

347

HTML

2580

Figures (1-1)

258

Tables (1-4)

249

Sum=3434

Mar 15, 2003 (publication date) through Feb 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Mar 15, 2003; 9(3): 534-538
Published online Mar 15, 2003. doi: 10.3748/wjg.v9.i3.534

Table 1 Characteristics of control and cirrhotic rats

	Control rats	Cirrhotic rats
Number of animal	25	25
IBO(%)	0	20/25(80%)^b
Total jejunal bacteria contents (CFU/mL)	0.54 ± 0.18	1.59 ± 0.48^b
Bacterial translocation(%)	0	12/25(48%)^b
Endotoxin level(pg/mL)	0.11 ± 0.058	0.648 ± 0.134^b
Intestinal transit (geometric center ratio)	0.49 ± 0.08	0.31 ± 0.06^a
Intestinal permeability (%urinary excretionof ^99mTc-DTPA)	1.62 ± 0.8	16.1 ± 7.6^b

^bP < 0.01 vs control rats;

^aP < 0.05 vs control rats.

Citation: Zhang SC, Wang W, Ren WY, He BM, Zhou K, Zhu WN. Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis. World J Gastroenterol 2003; 9(3): 534-538
URL: https://www.wjgnet.com/1007-9327/full/v9/i3/534.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i3.534